Hubei Guangji Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 178.87 million compared to CNY 176.33 million a year ago. Revenue was CNY 178.87 million compared to CNY 176.33 million a year ago. Net income was CNY 8.36 million compared to CNY 13.84 million a year ago. Basic earnings per share from continuing operations was CNY 0.0243 compared to CNY 0.0556 a year ago. Diluted earnings per share from continuing operations was CNY 0.0237 compared to CNY 0.0556 a year ago.